Company intelligence / Profile preview
江苏德迈药业
Taizhou, Jiangsu, Chinademaipharm.com ↗
- Ownership
- Private
- Development stage
- Other
01
Overview
Jiangsu Demai Pharmaceutical is a biopharmaceutical company based in the China Medical City of Taizhou, Jiangsu. The company specializes in the research, development, and manufacturing of innovative small molecule drugs and high-end generic medications. Its primary therapeutic focus areas include oncology, cardiovascular diseases, and metabolic disorders. Demai Pharmaceutical operates integrated R&D and manufacturing facilities that adhere to GMP standards. The company is dedicated to providing high-quality, cost-effective therapeutic options to the Chinese healthcare market. It is recognized as a high-tech enterprise within the regional pharmaceutical cluster.
- Therapeutic areas
- CardiovascularOncologyMetabolic Disorders
- Modalities
- Small molecule
- Industry
- Pharma
02
Drug pipeline
1 assetBeyond the preview
Go deeper on 江苏德迈药业.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on 江苏德迈药业.